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low up of 37.6 months, the overall 5-year survival was 40-68% 
after complete surgical resection, and the mean 5-year disease-
free survival after complete resection was 19.5-34.4%. Recent 
reports reflect better treatment outcomes, but not come to the 
of all the patients [4]. Traditional risk factors and selection cri-
teria are currently being discussed, but decision making pre-
supposes a personalized strategy with predictive models. Such 
predictive models have a number of uses. In particular, due to 
the selection of patients who might benefit from such treatment 
modalities as neoadjuvant chemotherapy prior to a prethora-
cotomy, surgery, or active chemotherapies, those with good 
prognostic factors can receive the surgical treatment at earlier 
times and those with a poor prognosis are subject to delayed 
surgery. This delay, or “trial of time,” can allow a better assess-
ment of additional disease and provide time for neoadjuvant 
therapy or more aggressive adjuvant therapy. Further, it can 
also be used to enroll patients who are at increased risks of 
recurrence in prospective randomized trials and can provide 
a postoperative surveillance strategy following the actual sur-
gery [5]. 
On a multivariate analysis, Kanemitsu et al. [6] maintained 
that five prognostic factors, the primary histology, hilar or me-
diastinal lymph node involvement, the number of metastases, 
the preoperative level of the carcinoembryonic antigen, and 
extrathoracic disease, would be risk factors. These factors have 
a prognostic value for long-term survival, and related study 
models are advantageous in that the degree of clinical applica-
bility is relatively higher. In addition, other prognostic factors 
affecting the survival rate following the pulmonary resection 
include a disease-free interval during which a diagnosis of pul-
monary lesions is made. As shown in this study, however, there 
was no significant difference. 
In recent years, as a prognostic factor for pulmomary metas-
tasis, genetic tests based on such technologies as the Affymetrix 
Gene Chip microarray have been applied. However, because of 
the prohibitive costs, reliance on frozen tissue, and advanced 
technical expertise required to use the technology, it is debat-
able whether such tests will ever be clinically applicable [7]. 
Thus, the immunohistochemical (IHC) staining profile can be 
a useful surrogate for gene expression analysis. Many studies 
Pulmonary resection of metastatic colorectal cancer is widely 
practiced in the field of oncologic surgery. However, only a 
highly selected subset of patients is eligible for resection, and 
the average recurrence rate is still high. According to general 
guidelines proposed by the UK National Institute for Clinical 
Excellence [1] and the National Comprehensive Cancer Net-
work [2], however, for the following cases of metastatic pul-
monary lesions, surgery is indicated:
1) the metastases seem to be technically resectable,
2) the general and functional risks are tolerable,
3) the primary tumor is controlled, and
4) no extrathoracic lesions are detected (with the exception 
of hepatic lesions for which both the hepatic and the pulmo-
nary metastases can be completely removed).
According to a review of the literature on surgical manage-
ment of a pulmonary metastasis of colorectal cancer, the re-
sults vary depending on the selection criteria of individual 
surgeons or institutions. Due to the problems associated with 
a lack of randomized, prospective clinical studies, it remains 
difficult from an evidence-based perspective to assess or sum-
marize the clinical usefulness of surgical management for met-
astatic lesions [3]. To date, however, most of the retrospective 
studies have demonstrated that a surgical resection of the pul-
monary metastasis of colorectal cancer is a safe treatment mo-
dality with a lower degree of mortality. 
The following meta-analysis for a pulmonary metastasectomy 
in cases of colorectal cancer showed that for all 1,307 patients 
investigated, a minimum number of 40 cases with a mean fol-
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have focused on the correlation between histopathologic and 
IHC measurements and survival [8, 9]. According to Shiono 
et al. [9] the histopathologic features of pulmonary metastases 
in 87 patients revealed the morphologic feature of an aeroge-
nous spread with floating cancer cell clusters and vascular in-
vasion at metastatic sites to be a prognostic factor of signifi-
cance for survival. Lymphatic invasion or microsatellite insta-
bility of the primary tumor, however, has been reported to be 
unrelated to survival. Although smaller in number, with the 
recent advancement in molecular biological methods, ongo-
ing studies are being conducted to examine the pulmonary 
metastasis of colorectal cancer. These studies will provide us 
further understanding of pulmonary metastatic cascade and 
allow patient treatment to be personalized. 
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